Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-057556

Chief Scientific Officer sold 3,000 shares at an average $69.69 ($209,071)

  • Chief Scientific Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Biller Scott Chief Scientific Officer 2018-11-05 Option exercise +3,000 $9.05 $27,150 53,932 D
Biller Scott Chief Scientific Officer 2018-11-05 Sale −2,200 $69.44 $152,768 51,732 D
Biller Scott Chief Scientific Officer 2018-11-05 Sale −700 $70.23 $49,161 51,032 D
Biller Scott Chief Scientific Officer 2018-11-05 Sale −100 $71.42 $7,142 50,932 D
Derivatives
Biller Scott Chief Scientific Officer 2018-11-05 Option exercise · Stock options (right to buy) −3,000 4,154 D
Open-market sales · 3,000 sh · avg $69.69 · $209,071
Loading xslF345X03/doc4.xml…